Article

VA testing app debuts on iPad

A feature-rich FLEX visual acuity (VA) app for ophthalmology, optometry, clinical trials, and other medical uses has been released on Apple iTunes for retina display iPad devices as an add-in to Konan Medical’s Chart2020 Duo app.

 

Irvine, CA-A feature-rich FLEX visual acuity (VA) app for ophthalmology, optometry, clinical trials, and other medical uses has been released on Apple iTunes for retina display iPad devices as an add-in to Konan Medical’s Chart2020 Duo app.

The app allows clinicians to adjust VA test parameters to test from 33 cm (14 inches) to 6 m (20 ft.), and includes industry standard, Sloan specification literate, illiterate, and pediatric optotypes for western and 6 global languages. The app is also gesture-driven to display acuity lines, single letters, and full charts, including smart randomization and reverse contract on retina display iPad devices.

“(The app) marks a new chapter in our vision assessment products, bringing professional-grade VA tests onto high resolution mobile devices, such as Apple’s retina display iPads,” said Charles Wm. Stewart, OD, chief executive officer of Konan Medical USA. “We have previewed (the app) with ophthalmologists and optometrists for standard VA testing, out of office screenings, clinical trials, school nurses, and even with emergency rooms physicians to bring the vision tests to patients.”

Konan is making complementary apps available, in quantities limited by Apple’s terms and conditions, to academic institutions, optometry students, ophthalmology residents, and other qualified settings.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.